Springleaf Mortgage Loan Trust 2012-2 $970.034 Million Notes Assigned Preliminary Ratings Jul 12

  • ID: 2201710
  • July 2012
  • Standard & Poors
1 of 3

OVERVIEW Springleaf Mortgage Loan Trust 2012-2's issuance is a RMBS securitization backed by seasoned first-lien, fixed-rate, and adjustable-rate, residential mortgage loans secured by one- to four-family residences, manufactured housing, land, and packages of multiple real properties to subprime borrowers. We assigned our preliminary ratings to the class A, M-1, M-2, M-3, M-4, B-1, and B-2 notes. The preliminary ratings reflect our view of the transaction's expected credit enhancement, the timing of losses, the foreclosed properties' recovery values, and our default assumptions, among other factors. NEW YORK (Standard & Poor's) July 31, 2012--Standard & Poor's Ratings Services today assigned its preliminary ratings to Springleaf Mortgage Loan Trust 2012-2's $970.034 million mortgage-backed notes series 2012-2 (see list). The note issuance is a...

Companies mentioned in this report are: Springleaf Mortgage Loan Trust 2012-2
Action: Preliminary Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Springleaf Mortgage Loan Trust 2012-2

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.